|
Q4 FY2019
As of Dec 29, 2019
|
Q3 FY2019
As of Sep 29, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 30, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jul 1, 2018
|
Q1 FY2018
As of Apr 1, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Oct 1, 2017
|
Q2 FY2017
As of Jul 2, 2017
|
Q1 FY2017
As of Apr 2, 2017
|
Q4 FY2016
As of Jan 1, 2017
|
Q3 FY2016
As of Oct 2, 2016
|
Q2 FY2016
As of Jul 3, 2016
|
Q1 FY2016
As of Apr 3, 2016
|
Q4 FY2015
As of Jan 3, 2016
|
Q3 FY2015
As of Sep 27, 2015
|
Q2 FY2015
As of Jun 28, 2015
|
Q1 FY2015
As of Mar 29, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and employee benefits | ||||||||||||||||||||
| Price adjustments and other distributor related reserves | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Credit facility and long-term debt | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (Note 23) | ||||||||||||||||||||
| Stockholder's Equity: | ||||||||||||||||||||
| Preferred stock, $.01 par value, 5,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock, $.01 par value, 650,000 and 650,000 shares authorized; 549,545 and 537,327 shares issued; 372,704 and 361,452 shares outstanding at December 29, 2019 and December 30, 2018, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders’ equity before treasury stock | ||||||||||||||||||||
| Less: shares of common stock held in treasury, at cost; 176,841 and 175,875 shares at December 29, 2019 and December 30, 2018, respectively | ||||||||||||||||||||
| Total Cypress stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
